{"count": 1, "results": [{"_id": "11397960", "pmid": 11397960, "title": "Inhibition of interferon-gamma-mediated microvascular endothelial cell major histocompatibility complex class II gene activation by HMG-CoA reductase inhibitors.", "journal": "Transplantation", "authors": ["Sadeghi MM", "Tiglio A", "Sadigh K", "O'Donnell L", "Collinge M", "Pardi R", "Bender JR"], "date": "2001-05-15T00:00:00Z", "doi": "10.1097/00007890-200105150-00014", "meta_date_publication": "2001 May 15", "meta_volume": "71", "meta_issue": "9", "meta_pages": "1262-8", "score": 50062.023, "text_hl": "...BACKGROUND: @<m>DISEASE_Graft_Occlusion_Vascular</m> @DISEASE_MESH:D006083 @@@Graft vascular disease@@@, a major cause of late graft failure in cardiac transplant @SPECIES_9606 @@@patients@@@, is associated with the presence of class II major histocompatibility complex molecules on the endothelium. 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors, e.g., @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@, have been shown to reduce the incidence of @<m>DISEASE_Graft_Occlusion_Vascular</m> @DISEASE_MESH:D006083 @@@graft vascular disease@@@. ", "citations": {"NLM": "Sadeghi MM, Tiglio A, Sadigh K, O'Donnell L, Collinge M, Pardi R, Bender JR. Inhibition of interferon-gamma-mediated microvascular endothelial cell major histocompatibility complex class II gene activation by HMG-CoA reductase inhibitors. Transplantation. 2001 May 15;71(9):1262-8. PMID: 11397960", "BibTeX": "@article{11397960, title={Inhibition of interferon-gamma-mediated microvascular endothelial cell major histocompatibility complex class II gene activation by HMG-CoA reductase inhibitors.}, author={Sadeghi MM and Tiglio A and Sadigh K and O'Donnell L and Collinge M and Pardi R and Bender JR}, journal={Transplantation}, volume={71}, number={9}, pages={1262-8}}"}}]}